HER-2 Positive Colorectal Cancer
1 clinical trials · Condition
◉ Watch HER-2 Positive Colorectal Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal Cancer (NCT04227041) | Qingdao Zhixin Health Technology Co., Ltd. | 2020-01-10 |
Track HER-2 Positive Colorectal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.